Investor Characteristics and Startups Decision

Last registered on October 12, 2023

Pre-Trial

Trial Information

General Information

Title
Investor Characteristics and Startups Decision
RCT ID
AEARCTR-0007973
Initial registration date
September 20, 2021

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
September 20, 2021, 6:10 PM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Last updated
October 12, 2023, 6:51 PM EDT

Last updated is the most recent time when changes to the trial's registration were published.

Locations

Region

Primary Investigator

Affiliation
Columbia University

Other Primary Investigator(s)

PI Affiliation
Stanford Graduate School of Business
PI Affiliation
Hong Kong University of Science and Technology

Additional Trial Information

Status
Completed
Start date
2021-10-31
End date
2022-08-31
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
This study uses a field experiment to study the discrimination and sustainable finance issues in the US venture capital industry.
External Link(s)

Registration Citation

Citation
Feng, Junlong, Ye Zhang and Weijie Zhong. 2023. "Investor Characteristics and Startups Decision." AEA RCT Registry. October 12. https://doi.org/10.1257/rct.7973-1.4
Sponsors & Partners

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information
Experimental Details

Interventions

Intervention(s)
Intervention Start Date
2022-01-01
Intervention End Date
2022-03-31

Primary Outcomes

Primary Outcomes (end points)
We have four co-primary outcome variables, which are the four designed evaluation questions. The most important primary outcome variable is startup founders' contact interest ratings.
Details are provided in the attached "pre-registration plan.pdf".
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
We also record the time spent on evaluating each investor profile in order to test founders' implicit bias based on gender, race or investors' ESG-related characteristics. Therefore, the evaluation time (measured in milliseconds) also serves as the outcome variable.
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
Details are provided in the attached "pre-registration plan.pdf".
Experimental Design Details
Details are provided in the attached "pre-registration plan.pdf".
Randomization Method
Details are provided in the attached "pre-registration plan.pdf".
Randomization Unit
Details are provided in the attached "pre-registration plan.pdf".
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
1000 startup founders
Sample size: planned number of observations
20,000 observations
Sample size (or number of clusters) by treatment arms
N/A
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
IRB

Institutional Review Boards (IRBs)

IRB Name
Columbia University IRB
IRB Approval Date
2020-01-24
IRB Approval Number
Protocol 8362
Analysis Plan

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Post-Trial

Post Trial Information

Study Withdrawal

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Intervention

Is the intervention completed?
No
Data Collection Complete
Data Publication

Data Publication

Is public data available?
No

Program Files

Program Files
Reports, Papers & Other Materials

Relevant Paper(s)

Reports & Other Materials